Veteran investment executive focused on growth-stage healthcare and tech opportunities, with operating experience in corporate strategy and M&A. Melissa Imbrogno brings experience across private equity, corporate development and portfolio company leadership, often leading due diligence, operational improvement programs and capital raises. Market-facing profile: active deal leader, board observer and strategic operator supporting scaling and exits.
Veteran investment executive focused on growth-stage healthcare and tech opportunities, with operating experience in corporate strategy and M&A. Melissa Imbrogno brings experience across private equity, corporate development and portfolio company leadership, often leading due diligence, operational improvement programs and capital raises. Market-facing profile: active deal leader, board observer and strategic operator supporting scaling and exits.
Focuses on growth-stage healthcare and technology companies where operational intervention accelerates scale and exit value. Prefers equity-led primers and control/minority positions that enable active board or operator influence, prioritizing durable revenue models, differentiated clinical or tech moats, and capital-efficient commercialization pathways. Investment cadence balances rigorous due diligence, hands-on post-close operational improvement and targeted follow-on capital to de-risk milestones over a 3–7 year horizon with disciplined downside protection and exit orientation.
Focuses on growth-stage healthcare and technology companies where operational intervention accelerates scale and exit value. Prefers equity-led primers and control/minority positions that enable active board or operator influence, prioritizing durable revenue models, differentiated clinical or tech moats, and capital-efficient commercialization pathways. Investment cadence balances rigorous due diligence, hands-on post-close operational improvement and targeted follow-on capital to de-risk milestones over a 3–7 year horizon with disciplined downside protection and exit orientation.
| Trades 1022 | Longs Won 764/1022 74% | Profit Factor 16.11 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $382,350.03 |
| Average Win $127,893.44 | Best Trade (Jul 15) $5.65M | Sharpe Ratio -84.65 |
| Average Loss -$23,512.27 | Worst Trade (Jul 13) -$645,419.27 | Z-Score 12.5 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 3w 2d | Expectancy $89,671.65 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,857 | 16,071 | 14,286 | 12,500 | 10,714 | 8,929 | 7,143 | 5,357 | 3,571 | 1,786 |